News
GlobalData on MSN2mon
Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adultsNeurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 ...
The drug – which works as a beta blocker as well as inhibiting vesicular monoamine transporter 2 (VMAT2) – is already sold by Nippon Chemiphar as Calvan for the treatment of hypertension in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback